eCoil™ Thought Leader Testimonials

Physicians and researchers are already using the eCoil for prostate imaging in 3.0T. Here is what they say about their experience.

SNR and Image Quality, Cancer Staging

‘’With the introduction of clinical 3.0T scanners, the quest for more accurate staging of prostate cancer has begun. Using the Endorectal coil at 3.0T results in such an enormous gain in spatial resolution that accurate detection of extracapsular tumor growth, in the millimeter range, is possible. A definite must for every Genito-urinary radiologist.’’."
- Dr. Jelle Barentsz, Full Professor, University Medical Center - Nijmegen

"Endorectal coil MR imaging at 1.5T has established itself as the cornerstone of localization and detection of prostate cancer. The gain in SNR and image quality is so much that imaging the prostate without the endorectal coil is unthinkable."
- Dr. Jelle Barentsz, Full Professor, University Medical Center - Nijmegen

"The endorectal coil yields exquisite signal for imaging of the prostate enabling high spatial resolution imaging."
- Dr Keyanoosh Hosseinzadeh, MD, Chief of Body MRI, University of Pittsburgh

Intracapsular and Extracapsular Disease

“Anatomic information from the combined MEDRAD 3.0T eCoil™ and MEDRAD Spectris Solaris-injected contrast enhancement images has enabled better distinction between intracapsular and extracapsular disease.”
– Dr Neil Rofsky, Beth Israel Deaconness, Harvard Medical School

3.0T MRI for Prostate

“The MEDRAD 3.0T eCoil™ unleashes the power of 3.0T MRI for Prostate Imaging. Prostate Imaging with an endorectal coil at 3.0T shows great potential to advance prostate cancer management with state of the art high-resolution images, perfusion, and spectroscopy.”
– Dr Larry Tanenbaum, Edison Imaging Associates

Prostate Cancer Diagnosis and Treatment

“MEDRAD 3.0T eCoil™ can aid in the early diagnosis of prostate cancer and optimize treatment options for patients.”
- Dr Neil Rofsky, Beth Israel Deaconness, Harvard Medical School

Choline Resonance

“The increased spectral dispersion obtained at 3.0T allows for better quantification of metabolites, notably the elevation of choline resonance, which has emerged as the most specific marker for prostate cancer.”
– John Kurhanewicz, Ph.D. University of California, San Francisco

Treatment Planning

“Endorectal Prostate MRI and the addition of high spatial DCE-MRI facilitate appropriate treatment planning.”
– Dr Nicolas Bloch, Beth Israel Deaconness, Harvard Medical School